David E Weng, MD is a healthcare provider in Chevy Chase, MD specialising in medical oncology. David trained at Johns Hopkins University School of Medicine, graduating in 1992.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Dr. Weng is a medical oncology in Chevy Chase, MD. This is the primary taxonomy recorded against the NPI in the federal registry, listed there as “MEDICAL ONCOLOGY”.
NPI registry
Dr. Weng is listed at 9017 SPRING HILL LN, Chevy Chase, MD 20815. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (301) 652-7370. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Dr. Weng's National Provider Identifier is 1831154731. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Weng attended Johns Hopkins University School of Medicine, graduating in 1992. This comes from the CMS National Downloadable File.
CMS public data
Dr. Weng has 34 years experience. Calculated from a graduation year of 1992, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Weng provides treatments such as administration of chemotherapy into vein, 1 hour or less and infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Weng. If this is you, claiming it is free.
Guide.md
Source: NPPES NPI Registry
9017 SPRING HILL LN
Chevy Chase, MD 20815
45,955 services · 2,377 patients · 25 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
445 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
299 |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
274 |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
252 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96402 |
109 |
| Administration of additional new drug or substance into vein, 1 hour or less | Treatment | 96417 |
105 |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
20,400 |
| Injection, denosumab, 1 mg | Drug given | J0897 |
7,440 |
| Injection, aprepitant, 1 mg | Drug given | J0185 |
7,410 |
| Injection, dexamethasone sodium phosphate, 1 mg | Drug given | J1100 |
1,706 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Verify your identity to control how patients — and AI assistants — describe you.
Claim this profileConnections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Same specialty, same city.
Other providers in the same specialty who trained at the same institution.
Providers who graduated from the same medical school in the same year.
Providers in MD who bill this service to Medicare most often.
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.